|
HRTX Heron Therapeutics Inc 818033 |
| Balance Sheet |
|
Current Assets
|
$229,845,000.00 |
|
Assets
|
$252,262,000.00 |
|
Current Liabilities
|
$92,145,000.00 |
|
Liabilities
|
$245,354,000.00 |
|
Equity
|
$6,908,000.00 |
|
Shares Out
|
188314430.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,753,000.00 |
|
Investing Cash Flow
|
$-4,204,000.00 |
| Market Analysis |
Market Cap
|
$58,377,473.30 |
|
Price
|
$0.31 |
|
BVPS
|
0.04 |
|
PB
|
7.75 |
|
EPS
|
-0.03 |
|
PS
|
0.39 |
|
FCF
|
$-4,282,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:52 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:43 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.02 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-11 |
-0.04 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-08 |
-0.02 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.10 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view HRTX documents filed with the SEC.
HRTX Filings
Clear
